27. Februar 2027
FDA PDUFA target action date for zipalertinib, a NDA from Cullinan Therapeutics and Taiho Pharmaceutical. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
FDA-PDUFA-Entscheidungstermine-Kalender